{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:30:40Z","timestamp":1784140240304,"version":"3.55.0"},"reference-count":65,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Ovarian cancer has the highest mortality rate among gynecological tumors. This is based on late diagnosis and the lack of early symptoms. To improve early detection, it is essential to find reliable biomarkers. The metalloprotease ADAM17 could be a potential marker, as it is highly expressed in many solid tumors, including ovarian and breast cancer. The aim of this work is to evaluate the relevance of ADAM17 as a potential diagnostic blood-based biomarker in ovarian cancer. Ovarian cancer cell lines IGROV-1 and A2780, as well as primary patient-derived tumor cells obtained from tumor tissue and ascitic fluid, were cultured to analyze ADAM17 abundance in the culture supernatant. In a translational approach, a cohort of 117 well-characterized ovarian cancer patients was assembled and ADAM17 levels in serum and corresponding ascitic fluid were determined at primary diagnosis. ADAM17 was quantified by enzyme-linked immunosorbent assay (ELISA). In the present study, ADAM17 was detected in the culture supernatant of ovarian cancer cell lines and primary cells. In addition, ADAM17 was found in serum and ascites of ovarian cancer patients. ADAM17 level was significantly increased in ovarian cancer patients compared to an age-matched control group (p &lt; 0.0001). Importantly early FIGO I\/II stages, which would not have been detected by CA-125, were associated with higher ADAM17 concentrations (p = 0.007). This is the first study proposing ADAM17 as a serum tumor marker in the setting of a gynecological tumor disease. Usage of ADAM17 in combination with CA-125 and other markers could help detect early stages of ovarian cancer.<\/jats:p>","DOI":"10.3390\/cancers13215563","type":"journal-article","created":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T20:41:14Z","timestamp":1636317674000},"page":"5563","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["ADAM17\u2014A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer"],"prefix":"10.3390","volume":"13","author":[{"given":"Christoph","family":"Rogmans","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Dominik","family":"Kuhlmann","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01219 Dresden, Germany"},{"name":"National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische, Universit\u00e4t Dresden, Dresden, Germany, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany"},{"name":"German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Hugendieck","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Link","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01219 Dresden, Germany"},{"name":"National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische, Universit\u00e4t Dresden, Dresden, Germany, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany"},{"name":"German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-8509","authenticated-orcid":false,"given":"J\u00f6rg Paul","family":"Weimer","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5885-6352","authenticated-orcid":false,"given":"Inken","family":"Fl\u00f6rkemeier","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Christina","family":"Rambow","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-4460","authenticated-orcid":false,"given":"Wolfgang","family":"Lieb","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Maass","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk O.","family":"Bauerschlag","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Hedemann","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,6]]},"reference":[{"key":"ref_1","first-page":"465","article-title":"Natural history of ovarian cancer","volume":"8","author":"Vargas","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"ref_2","first-page":"519","article-title":"Ovarian cancer: Diagnostic, biological and prognostic aspects","volume":"10","author":"Davidson","year":"2014","journal-title":"Women\u2019s Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","first-page":"1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the paltinum era: A meta-analysis","volume":"20","author":"Bristow","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_5","first-page":"2","article-title":"[Early detection and preoperative diagnosis of ovarian carcinoma]","volume":"146","author":"Kainz","year":"1996","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: A review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Hum. Reprod."},{"key":"ref_7","first-page":"197","article-title":"Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9","volume":"13","author":"Quentmeier","year":"1987","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004347-198303000-00005","article-title":"Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125","volume":"2","author":"Kabawat","year":"1983","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-10-0195","article-title":"Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens","volume":"4","author":"Cramer","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: Comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumour Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.febslet.2006.11.074","article-title":"Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17","volume":"581","author":"Sahin","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Richards, F.M., Tape, C.J., Jodrell, D.I., and Murphy, G. (2012). Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040597"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16043","DOI":"10.18632\/oncotarget.24682","article-title":"ADAM17 inhibition enhances platinum efficiency in ovarian cancer","volume":"9","author":"Hedemann","year":"2018","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Fabre-Lafay, S., Monville, F., Garrido-Urbani, S., Berruyer-Pouyet, C., Ginestier, C., Reymond, N., Finetti, P., Sauvan, R., Ad\u00e9la\u00efde, J., and Geneix, J. (2007). Nectin-4 is a new histological and serological tumor associated marker for breast cancer. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-73"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1074\/jbc.M116.746859","article-title":"Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17","volume":"292","author":"Buchanan","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/annonc\/mdm609","article-title":"ADAM-17 predicts adverse outcome in patients with breast cancer","volume":"19","author":"McGowan","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.59566\/IJBS.2014.10229","article-title":"Reduction of serum ADAM17 level accompanied with decreased cytokines after abatacept therapy in patients with rheumatoid arthritis","volume":"10","author":"Umemura","year":"2014","journal-title":"Int. J. Biomed. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000166359.47577.57","article-title":"Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-\u03b1 release in patients with severe peritonitis: Role of tumor necrosis factor-\u03b1 converting enzyme cleavage","volume":"33","author":"Kermarrec","year":"2005","journal-title":"Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5035234","DOI":"10.1155\/2019\/5035234","article-title":"Adamalysines as biomarkers and a potential target of therapy in colorectal cancer patients: Preliminary results","volume":"2019","author":"Walkiewicz","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1007\/s12032-011-0125-4","article-title":"Prognostic value of ADAM17 in human gastric cancer","volume":"29","author":"Zhang","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cca.2019.03.1621","article-title":"Metalloproteinases at the surface of small extrcellular vesicles in advanced ovarian cancer: Relationships with ascites volume and peritoneal canceromatosis index","volume":"494","author":"Yunusova","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1158\/1078-0432.CCR-04-1426","article-title":"Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer","volume":"11","author":"Tanaka","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00404-016-4018-9","article-title":"Alteration of STR profiles in ovarian carcinoma cells during primary culture","volume":"294","author":"Huang","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jim.2011.06.015","article-title":"Development of sandwich ELISA for detection and quantification of human and murine a disintegrin and metalloproteinase17","volume":"371","author":"Trad","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-61779-080-5_15","article-title":"Isolation and culture of ovarian cancer cells and cell lines","volume":"731","author":"Kurbacher","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12687-019-00417-8","article-title":"Linking pre-existing biorepositories for medical research: The PopGen 2.0 Network","volume":"10","author":"Lieb","year":"2019","journal-title":"J. Community Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"35067","DOI":"10.1038\/srep35067","article-title":"Control of ADAM17 activity by regulation of its cellular localisation","volume":"6","author":"Lorenzen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1097\/j.pain.0000000000001044","article-title":"Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation","volume":"158","author":"Scheff","year":"2017","journal-title":"Pain"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/bj3470131","article-title":"Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE)","volume":"347","author":"Becherer","year":"2000","journal-title":"Biochem. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.bbamcr.2016.09.002","article-title":"Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes","volume":"1863","author":"Groth","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/1541-7786.MCR-07-0366","article-title":"Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion","volume":"6","author":"Belotti","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00432-005-0030-3","article-title":"Coordinate cell-surface expression of matrix metalloproteinases and their inhibitors on cancer-associated myofibroblasts from malignant ascites in patients with gastric carcinoma","volume":"131","author":"Koyama","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1309\/AJCPGXK0FR4MHIHB","article-title":"Nectin 4 overexpression in ovarian cancer tissues and serum","volume":"134","author":"DeRycke","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/ijc.32676","article-title":"Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer","volume":"146","author":"Link","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/107327481101800103","article-title":"Screening for ovarian cancer","volume":"18","author":"Cragun","year":"2011","journal-title":"Cancer Control."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejcb.2010.11.005","article-title":"The \u201cA disintegrin and metalloproteases\u201d ADAM10 and ADAM17: Novel drug targets with therapeutic potential?","volume":"90","author":"Saftig","year":"2011","journal-title":"Eur. J. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.200307137","article-title":"Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands","volume":"164","author":"Sahin","year":"2004","journal-title":"J. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1432-0436.2007.00198.x","article-title":"TACE: A new target in epidermal growth factor receptor dependent tumors","volume":"75","author":"Kenny","year":"2007","journal-title":"Differentiation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","article-title":"An Essential Role for Ectodomain Shedding in Mammalian Development","volume":"282","author":"Peschon","year":"1998","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1158\/1078-0432.CCR-06-2092","article-title":"ADAM-17 expression in breast cancer correlates with variables of tumor progression","volume":"13","author":"McGowan","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/biolreprod\/85.s1.748","article-title":"ADAM17 Expression is increased in epithelial ovarian carcinoma","volume":"85","author":"Tapia","year":"2011","journal-title":"Biol. Reprod."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2249.2010.04298.x","article-title":"ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers","volume":"163","author":"Sinnathamby","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00018-019-03184-4","article-title":"Degradome of soluble ADAM10 and ADAM17 metalloproteases","volume":"77","author":"Scharfenberg","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ijc.25746","article-title":"Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form","volume":"129","author":"Mongaret","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-140177","article-title":"Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease","volume":"41","author":"Sun","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"iii101","DOI":"10.1093\/neuonc\/nox036.386","article-title":"P13.03 Profiling protease activities in cerebrospinal fluids: A novel method for detection of neoplastic meningitis?","volume":"19","author":"Conrad","year":"2017","journal-title":"Neuro. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","article-title":"A tumor necrosis factor-\u03b1-mediated pathway promoting autosomal dominant polycystic kidney disease","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jprot.2016.05.005","article-title":"A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics","volume":"145","author":"Poersch","year":"2016","journal-title":"J. Proteomics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/ijc.27948","article-title":"Activated leukocyte cell adhesion molecule soluble form: A potential biomarker of epithelial ovarian cancer is increased in type II tumors","volume":"132","author":"Carbotti","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1054\/bjoc.2001.2030","article-title":"A prognostic model for ovarian cancer","volume":"85","author":"Clark","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_53","first-page":"378","article-title":"Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage","volume":"138","author":"Fures","year":"1999","journal-title":"Coll. Antropol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0412.1992.tb00012.x","article-title":"What do CA 125 and other antigens tell us about ovarian cancer biology?","volume":"155","author":"Welander","year":"1992","journal-title":"Acta Obstet. Gynecol. Scand. Suppl."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0090-8258(90)90393-Y","article-title":"Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: Influence of histological type, grade of differentiation, and clinical stage of disease","volume":"39","author":"Tholander","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"ref_56","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma: Seminar on ovarian cancer","volume":"42","author":"Griffiths","year":"1975","journal-title":"J. Natl Cancer Inst. Monogr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/172460089701200305","article-title":"Clinical significance of preoperative serum levels of CA 125 and TAG-72 in ovarian carcinoma","volume":"12","author":"Gonzalez","year":"1997","journal-title":"Int. J. Biol. Markers"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00404-002-0404-6","article-title":"A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer","volume":"269","author":"Rossi","year":"2004","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1582-4934.2006.tb00530.x","article-title":"Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed","volume":"10","author":"Ganss","year":"2006","journal-title":"J. Cell. Mol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1593\/neo.101720","article-title":"Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer","volume":"13","author":"Schauer","year":"2011","journal-title":"Neoplasia"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Cury, P.M., de Carvalho, M.B., Dias-Neto, E., Figueiredo, D.L.A., Fukuyama, E.E., G\u00f3is-Filho, J.F., Leopoldino, A.M., Mamede, R.C.M., Michaluart-Junior, P., and Moyses, R.A. (2010). Genomics and proteomics approaches to the study of cancer-stroma interactions. BMC Med. Genom., 3.","DOI":"10.1186\/1755-8794-3-14"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V118.21.2184.2184","article-title":"ADAM17, a novel metalloproteinase, mediates CD16 and CD62L shedding in human NK cells and modulates IFN\u03b3 responses","volume":"118","author":"Romee","year":"2011","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-015-0144-7","article-title":"Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer","volume":"34","author":"Nishiwada","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/GCO.0b013e3283409c91","article-title":"Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy","volume":"23","author":"Tsujioka","year":"2011","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2013.05.011","article-title":"Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-\u03b1 cleavage by ADAM17","volume":"336","author":"Gao","year":"2013","journal-title":"Cancer Lett."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/21\/5563\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:26:47Z","timestamp":1760167607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/21\/5563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":65,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cancers13215563"],"URL":"https:\/\/doi.org\/10.3390\/cancers13215563","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]}}}